Find Articles



Return to:Anorexia Articles
Or:Recent Anorexia Articles

Array BioPharma Reports Positive New Data on ErbB-2 / EGFR Inhibitor ...


http://www.forbes.com/businesswire/feeds/businesswire/200...

Forbes - The most common adverse events included fatigue, nausea, anorexia, diarrhea and rash, which are all typically seen with tyrosine kinase inhibitors. Systemic concentrations of ARRY-543 increased with escalating doses at all dose levels tested and ARRY ...



Article Finder:

October 24, 2007 12:35:00 PM
Article Directory